Weed (BUDZ) EPS (Basic) Growth (1y) (2011 - 2026)
Weed (BUDZ) EPS (Basic) Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | -301.82% |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 1.21% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -17.09% |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 13.91% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -2,504.14% |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 31.67% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 388.06% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Weed | 2.88 Mn | 2.88 Mn | - | 3.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60.21% |
| Dec 31, 2025 | -1,493.05% |
| Sep 30, 2025 | 21.30% |
| Jun 30, 2025 | 1.34% |
| Mar 31, 2025 | -157.43% |
| Dec 31, 2024 | 66.33% |
| Sep 30, 2024 | -112.73% |
| Jun 30, 2024 | 97.28% |
| Mar 31, 2024 | 13.61% |
| Dec 31, 2023 | -102.36% |
| Sep 30, 2023 | 124.42% |
| Jun 30, 2023 | -27.82% |
| Mar 31, 2023 | 94.17% |
| Dec 31, 2022 | 60.66% |
| Sep 30, 2022 | -1,476.70% |
| Jun 30, 2022 | -139.38% |
| Mar 31, 2022 | -221.20% |
| Dec 31, 2021 | -131.33% |
| Sep 30, 2021 | 21.40% |
| Jun 30, 2021 | -104.19% |